Kimberly Manhard
Corporate Officer/Principal chez ACADIA PHARMACEUTICALS INC.
Profil
Kimberly J.
Manhard is currently the Director at Shoreline Biosciences, Inc. and Toragen, Inc. She is also an Independent Director at Inhibrx Biosciences, Inc. and a Trustee at The Fleet Science Center.
In her former positions, she served as the Director & Corporate Compliance Officer at Ardea Biosciences, Inc. from 2009 to 2016.
She was also an Independent Director at Inhibrx, Inc. from 2020 to 2024.
Additionally, she held the position of Executive Vice President-Drug Development at Heron Therapeutics, Inc. in 2023.
Ms. Manhard has a background in Regulatory Affairs and previously worked at Bristol Myers Squibb Co., Eli Lilly & Co., Exelixis, Inc., Agouron Global Commercial Operations, and G.H.
Besselaar Associates.
She obtained her undergraduate degree from the University of Florida.
Postes actifs de Kimberly Manhard
| Sociétés | Poste | Début |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 30/01/2024 |
| Fleet Science Center | Directeur/Membre du Conseil | - |
Shoreline Biosciences, Inc.
 Shoreline Biosciences, Inc. BiotechnologyHealth Technology Shoreline Biosciences, Inc. engages in biotechnology business activities. The company is headquartered in La Jolla, CA. | Directeur/Membre du Conseil | 19/05/2021 |
Toragen, Inc.
 Toragen, Inc. BiotechnologyHealth Technology Toragen, Inc. is a clinical-stage biotechnology company that is focused on developing treatments for HPV-induced cancers, starting with head and neck cancer. Toragen is based in San Diego, CA. The company is targeting the root cause of virally induced cancers. The company was founded by Andrew Sharabi and the CEO is Sandra I. Coufal. | Directeur/Membre du Conseil | 01/05/2020 |
Anciens postes connus de Kimberly Manhard
| Sociétés | Poste | Fin |
|---|---|---|
| INHIBRX, INC. | Directeur/Membre du Conseil | 30/05/2024 |
| HERON THERAPEUTICS, INC. | Directeur/Membre du Conseil | 21/02/2023 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Directeur des opérations | 23/06/2009 |
| EXELIXIS, INC. | Conseiller Juridique Général | 01/01/2003 |
| G.H. Besselaar Associates | Corporate Officer/Principal | - |
Formation de Kimberly Manhard
| University of Florida | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| EXELIXIS, INC. | Health Technology |
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Health Technology |
| Agouron Global Commercial Operations | |
| G.H. Besselaar Associates | |
Inhibrx, Inc.
 Inhibrx, Inc. BiotechnologyHealth Technology Inhibrx, Inc., is a clinical stage biotechnology company, focuses on developing pipeline of novel biologic therapeutic candidates. The firm’s pipeline is focused on oncology, orphan diseases and infectious diseases. It utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The company was founded by Mark Paul Lappe, Quinn Deveraux and Brendan P. Eckelman in April 2010 and is headquartered La Jolla, CA. | Health Technology |
Shoreline Biosciences, Inc.
Shoreline Biosciences, Inc. BiotechnologyHealth Technology Shoreline Biosciences, Inc. engages in biotechnology business activities. The company is headquartered in La Jolla, CA. | Health Technology |
| Fleet Science Center | |
Toragen, Inc.
Toragen, Inc. BiotechnologyHealth Technology Toragen, Inc. is a clinical-stage biotechnology company that is focused on developing treatments for HPV-induced cancers, starting with head and neck cancer. Toragen is based in San Diego, CA. The company is targeting the root cause of virally induced cancers. The company was founded by Andrew Sharabi and the CEO is Sandra I. Coufal. | Health Technology |
